Silk Road Therapies is paving the
way for rare disease treatments

Learn more

Silk Road Therapies

Silk Road Therapies, Inc. is a biopharmaceutical company dedicated to the development and commercialization of medicines for patients with rare (orphan) diseases.

Silk Road Therapies’ unique business model is to repropose well-understood active ingredients in existing, approved drug products, and to develop them into treatments for specific rare disease. This approach enables us to be able to develop and commercialize products much faster and cost effective.

Our business model pairs a core management team of rare disease experts with an extensive network of academic researchers, specialized consultants, third party service providers and contractors. We have expertise in clinical development, regulatory affairs, and commercialization of rare disease medicines.

learn more

Rare disease challenge

In the United States, more than 7,000 rare diseases collectively affect more than 25 million Americans.

Orphan diseases, including rare diseases, are neglected conditions whose treatments are often not considered profitable due to their cost to develop and limited patient population.

learn more
Privacy Settings
We use cookies to enhance your experience while using our website. If you are using our Services via a browser you can restrict, block or remove cookies through your web browser settings. We also use content and scripts from third parties that may use tracking technologies. You can selectively provide your consent below to allow such third party embeds. For complete information about the cookies we use, data we collect and how we process them, please check our Privacy Policy
Consent to display content from Youtube
Consent to display content from Vimeo
Google Maps
Consent to display content from Google